Hacettepe Health Cohort: A Prospective Follow-up of the General Health Status and Effectiveness, Durability and Adverse Effects of COVID-19 Vaccine Among Students of Medical and Dental Schools
Latest Information Update: 01 Mar 2024
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms HU-CoVaCS
- 27 Feb 2024 Status changed from active, no longer recruiting to completed.
- 22 Sep 2023 Planned End Date changed from 30 Sep 2023 to 7 Dec 2023.
- 22 Sep 2023 Planned primary completion date changed from 1 May 2023 to 7 Dec 2023.